Ecolab is scheduled to release second-quarter 2026 results on July 28 before the opening bell. The Zacks Consensus Estimate for revenues is pegged at $4.4 billion, indicating growth of 9.3% year over year, while the consensus mark for earnings is pinned at $2.08 per share, an improvement of 10.1%. The company is expected to have delivered another quarter of organic growth supported by value pricing and resilient demand, though elevated commodity, logistics and energy costs are expected to have pressured margins. Ecolab expects second-quarter 2026 to serve as a transition period, with pricing anticipated to have accelerated through the quarter to fully offset higher input costs by its end. The Zacks model does not predict an earnings beat, as the company carries a Zacks Rank #4 (Sell) and an Earnings ESP of +0.20%.
Alcon AG
Henry Schein IncEcolab IncRevenue growth driven by value pricing, but margins pressured by higher costs; pricing expected to offset costs by end of quarter.
Cardinal Health Inc